Health
Abridge lost AI scribing to Microsoft and Epic; its next market has a $100 million price from Wolters Kluwer
Microsoft and Epic took two of every three new AI-scribe dollars this year, and Abridge, which built that market, is selling what comes after the note. The decision-support category it is moving into just got a public price, Wolters Kluwer's $100 million AgileMD deal, and that price is what Abridge's $6.69 billion private mark has to outrun.
three-minute read